bioRxivBiochemistry
Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis
Marisa J. Brothwell, Guoshen CaoiD, J. Alan MaschekiD, Annelise M. PossiD, Alek D. PeterliniD, Liping WangiD, Talia B. Baker, Justin L. ShahtoutiD, Piyarat SiripoksupiD, Quentinn PearceiD, Jordan M. JohnsoniD, Fabian FingeriD, Alexandre ProlaiD, Sarah Pellizzari, Gillian HaleiD, Allison M. ManueliD, Shinya WatanabeiD, Edwin R. MirandaiD, Kajsa E. AffolteriD, Trevor S. TippettsiD, Linda S. Nikolova, Ran Hee ChoiiD, Stephen Thomas DeckeriD, Mallikarjun Patil, Jonathan Leon CatrowiD, , Katsuhiko FunaiiD
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive disorder marked by lipid accumulation, leading to metabolic dysfunction-associated steatohepatitis (MASH). A key feature of the transition to MASH involves oxidative stress resulting from defects in mitochondrial oxidative phosphorylation (OXPHOS). Here, we show that pathological alterations in the lipid composition of the inner mitochondrial membrane (IMM) directly instigate electron transfer inefficiency to promote oxidative stress. Specifically, mitochondrial cardiolipin (CL) was downregulated with MASLD/MASH in humans and in mice. Hepatocyte-specific CL synthase knockout (CLS-LKO) led to spontaneous and robust MASH with extensive steatotic and fibrotic phenotype. Loss of CL paradoxically increased mitochondrial respiratory capacity but also promoted electron leak primarily at sites IIIQO and IIF of the electron transport chain, reduced the formation of I+III2+IV respiratory supercomplex, and disrupted the propensity of coenzyme Q (CoQ) to become reduced. Thus, low mitochondrial CL disrupts electron transport chain to promote oxidative stress and contributes to pathogenesis of MASH.
- organism: human
- organism: mouse
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Translational Model of MASLD-Associated HFpEF Defines Mitochondrial Dysfunction and Cardiac Plasticity During Disease Progression and Regression
Souradipta Ganguly, Betul Beyza Gunes, … Debanjan Dhar·MetabolismPeer-reviewed·Jun 22, 2026
- Disrupted Mitochondrial Copper Homeostasis Promotes Ferroptotic Stress, Senescence and MASLD Progression
Niansheng Ren, Liuyang Wang, … Kuo Du·bioRxiv·Jun 17, 2026
- Ketogenesis protects against MASLD-MASH progression through mechanisms that extend beyond overall fat oxidation rate
Eric D. Queathem, David B. Stagg, … Peter A. Crawford·Journal of Clinical InvestigationPeer-reviewed·Apr 24, 2025
- Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis
Ikki Sakuma, Rafael Calais Gaspar, … Gerald I. Shulman·Proceedings of the National Academy of SciencesPeer-reviewed·May 1, 2025
- Interorganelle competition for linoleic acid underlies steatotic liver pathology
Chuanhai Zhang, Dengbao Yang, … Xing Zeng·bioRxiv·Jan 11, 2026
- A Host Enzyme Reduces Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by Inactivating Intestinal Lipopolysaccharide
Zhiyan Wang, Nore Ojogun, … Mingfang Lu·eLifePeer-reviewed·Oct 14, 2024